Noninfectious complications of hematopoietic cell transplantation

Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):578-586. doi: 10.1182/hematology.2021000293.

Abstract

Noninfectious lung diseases contribute to nonrelapse mortality. They constitute a spectrum of diseases that can affect the parenchyma, airways, or vascular pulmonary components and specifically exclude cardiac and renal causes. The differential diagnoses of these entities differ as a function of time after hematopoietic cell transplantation. Specific diagnosis, prognosis, and optimal treatment remain challenging, although progress has been made in recent decades.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Cytokine Release Syndrome / diagnosis
  • Cytokine Release Syndrome / etiology
  • Cytokine Release Syndrome / mortality
  • Cytokine Release Syndrome / therapy
  • Disease Management
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / mortality
  • Hemorrhage / diagnosis
  • Hemorrhage / etiology
  • Hemorrhage / mortality
  • Hemorrhage / therapy
  • Humans
  • Infant
  • Lung Diseases / diagnosis
  • Lung Diseases / etiology*
  • Lung Diseases / mortality
  • Lung Diseases / therapy
  • Male
  • Risk Factors
  • Thrombotic Microangiopathies / diagnosis
  • Thrombotic Microangiopathies / etiology
  • Thrombotic Microangiopathies / mortality
  • Thrombotic Microangiopathies / therapy